Pharmacology News and Research

Latest Pharmacology News and Research

UQ researchers discover a molecule essential for regulating nerve repair

Researchers at The University of Queensland have identified a molecule essential for regulating the repair of injured nerves, which could help people recover from nerve damage.

16 Mar 2022

New insight into how gut bacteria work to counter intestinal inflammation

Bile acids made by the liver have long been known for their critical role in helping to absorb the food we ingest.

16 Mar 2022

Discovery of key brain pathway offers potential new drug target for treating anxiety

A new target in the brain which underpins the eliciting of anxiety and fear behaviors such as 'freezing' has been identified by neuroscientists.

15 Mar 2022

Rat study shows how several brain regions work together to acquire a skill and replicate it

Learning a complex skilled movement like tying your shoes or playing an instrument takes practice. After repeating the same movements over and over, people often develop a formulaic way of performing the task, and may not even have to think about it anymore.

14 Mar 2022

Insight into oligodendrocytes in the brain could shed light on the causes of neurodegenerative diseases

New research may help scientists locate immature cells in the central nervous system that could shed light on the causes of neurodegenerative diseases like multiple sclerosis - and autoimmune disease that affects the brain and nervous system - and allow for the development of better therapeutic treatments.

12 Mar 2022

Alzheimer’s disease protein helps skin cancer cells thrive when they metastasize to the brain

Amyloid beta, a protein known to build up in the brains of people with Alzheimer's disease, also helps skin cancer cells thrive when they spread to the brain, a new study finds.

10 Mar 2022

A promising approach for COVID-19 prophylaxis

SARS-CoV-2 viruses can hide from recognition by the immune system. However, the antiviral immune receptor RIG-I can be stimulated, which improves protection against lethal SARS-CoV-2 infections.

8 Mar 2022

Study shows anti-itch and pain relief potential of protein in tick saliva

A protein found in tick saliva could be turned into a drug that eases itching and chronic pain in people.

8 Mar 2022

Study reveals the potential of novel antiviral drug combinations to stop COVID-19 spread

Researchers from Columbia Engineering, Fiocruz's Center for Technological Development in Health and the Oswaldo Cruz Institute in Brazil, Memorial Sloan Kettering Cancer Center, and Rockefeller University recently reported that, by combining inhibitors of polymerases and exonucleases--enzymes that allow SARS-CoV-2 to reproduce--they were able to reduce SARS-CoV-2 replication 10 times more than when using just the polymerase inhibitors.

7 Mar 2022

Researchers discover functional links between potassium channel gene variants and neonatal epilepsy

Northwestern Medicine scientists have discovered functional links between dozens of potassium channel gene variants and neonatal epilepsy, according to a study published in JCI Insight.

4 Mar 2022

High-fat diet combined with liquid fructose intake accelerates fat accumulation in the liver

A high-fat diet is not enough to cause short-term fatty liver disease. However, if this diet is combined with the intake of beverages sweetened with liquid fructose, the accumulation of fats in the liver accelerates and hypertriglyceridemia —a cardiovascular risk factor— can appear.

4 Mar 2022

Discovery could open new doors in the field of blood pressure research

The research group of internal medicine at the University of Oulu, Finland, has discovered a previously unknown blood pressure-regulating circuit.

4 Mar 2022

Study shows the viability of lung transplants in patients with COVID-19-associated ARDS

Patients with COVID-19-associated acute respiratory distress syndrome who received lung transplants had similar outcomes, compared to transplant patients without COVID-19, according to a Northwestern Medicine study published in JAMA.

2 Mar 2022

Peer-led online communities effective in increasing HIV self-testing among MSM of color

A new University of California, Irvine-led study, called the HOPE (Harnessing Online Peer Education) HIV study, revealed that using peer-led online communities was successful in increasing HIV self-testing and reducing alcohol consumption among Latinx and African American MSM (men who have sex with men).

28 Feb 2022

Scientists uncover new role of chromatin-modulatory enzyme during cancer development

Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new role of a chromatin-modulatory enzyme, termed EZH2, during cancer development.

24 Feb 2022

Discovery of signaling pathway in immune cells may lead to new therapeutic approach for autoimmune diseases

Autoimmune diseases are triggered when the immune system malfunctions and attacks the body's own structures.

23 Feb 2022

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the online publication of a new manuscript, Exosome mediated genetic reprogramming of tumor associated macrophages by exoASO-STAT6 leads to potent monotherapy anti-tumor efficacy, in the American Association for the Advancement of Science's journal, Science Advances.

18 Feb 2022

Inside the tactical tug of war over the controversial Alzheimer’s drug

The drug industry, patient advocates, and congressional Republicans have all attacked federal officials' decision to decline routine Medicare coverage for a controversial Alzheimer's drug.

16 Feb 2022

Human nose organoids provide better understanding of the first steps toward SARS-CoV-2 infection

Preclinical models that recapitulate aspects of human airway disease are essential for the advancement of novel therapeutics and vaccines.

16 Feb 2022

Phase one study of oral SARS-CoV-2 antiviral agent nirmatrelvir

A recent study posted to the medRxiv* preprint server reported the phase one pharmacokinetic and safety data of nirmatrelvir/ritonavir to facilitate its rapid progression to the last stages of clinical trials in coronavirus disease 2019 (COVID-19) patients with mild to moderate disease.

14 Feb 2022

Pharmacology News and Research

Latest Pharmacology News and Research

UQ researchers discover a molecule essential for regulating nerve repair

New insight into how gut bacteria work to counter intestinal inflammation

Discovery of key brain pathway offers potential new drug target for treating anxiety

Rat study shows how several brain regions work together to acquire a skill and replicate it

Insight into oligodendrocytes in the brain could shed light on the causes of neurodegenerative diseases

Alzheimer’s disease protein helps skin cancer cells thrive when they metastasize to the brain

A promising approach for COVID-19 prophylaxis

Study shows anti-itch and pain relief potential of protein in tick saliva

Study reveals the potential of novel antiviral drug combinations to stop COVID-19 spread

Researchers discover functional links between potassium channel gene variants and neonatal epilepsy

High-fat diet combined with liquid fructose intake accelerates fat accumulation in the liver

Discovery could open new doors in the field of blood pressure research

Study shows the viability of lung transplants in patients with COVID-19-associated ARDS

Peer-led online communities effective in increasing HIV self-testing among MSM of color

Scientists uncover new role of chromatin-modulatory enzyme during cancer development

Discovery of signaling pathway in immune cells may lead to new therapeutic approach for autoimmune diseases

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Inside the tactical tug of war over the controversial Alzheimer’s drug

Human nose organoids provide better understanding of the first steps toward SARS-CoV-2 infection

Phase one study of oral SARS-CoV-2 antiviral agent nirmatrelvir

Pittcon Highlights: Pharmaceutical & Biologic eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Pharmacology News and Research

Latest Pharmacology News and Research

Pittcon Highlights: Pharmaceutical & Biologic eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in